CASE REPORT article

Front. Pediatr.

Sec. Genetics of Common and Rare Diseases

Volume 13 - 2025 | doi: 10.3389/fped.2025.1617479

This article is part of the Research TopicGenetics and Mechanisms of Neurodevelopmental DisordersView all 3 articles

Diagnostic Assessment, Developmental Trajectory and Treatment Approaches in a case of a complex neurodevelopmental syndrome associated with non-synonymous variants in MECP2 ( p. R133C) and GABBR1

Provisionally accepted
  • 1Child and Adolescent Neuropsychiatry Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
  • 2Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
  • 3Department of Dynamic, Clinical Psychology and Health, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Lazio, Italy
  • 4Department of Humanities, University of Foggia, Foggia, Apulia, Italy
  • 5Developmental Neurology and Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
  • 6Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Rome, Lazio, Italy

The final, formatted version of the article will be published soon.

Background: Rett Syndrome (RTT) is an X-linked progressive disease affecting 1 in 10,000 females. MECP2 p.R133C is the second most common variant, present in more than 4% of all RTT cases. GABBR1 pathogenic variants have recently been associated with psychomotor delay, epilepsy, intellectual disability (ID), autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), and oppositional defiant disorder (ODD).Material and Methods: We report a 13.9-year-old girl with a complex neurodevelopmental disorder, including ASD and ID, with the onset at 9 years of age of vocal and motor tics involving the upper limbs and trunk, suggestive of Tourette syndrome (TS). Tics were also observed in the mother and grandmother. The patient was followed for approximately 10 years and underwent regular clinical and neuropsychological evaluations. Trio-based WES and segregation analysis were performed in relevant family members.Results: A de novo MECP2 variant (p.R133C) was detected in the proband. In addition, a maternally inherited class 3 VoUS in GABBR1 (p.F692S) was identified in the proband and segregated in the mother and grandmother. No functional studies confirm the pathogenicity of this GABBR1 variant, and TS has not previously been linked to GABBR1. Based on familial segregation, we hypothesize that this variant may exacerbate the MECP2-related phenotype and underlie TS symptoms in all carriers. Tourette phenotypes have not been reported with MECP2 variants alone. Although Rett features are mainly due to MECP2 loss-of-function, MECP2 deficiency disrupts GABAergic signaling. The GABBR1 variant may further impair GABA_B receptor function, contributing to late-onset regression, complex tics, skin-picking, and behavioral dysregulation beyond classic Z-RTT/PSV. Despite pharmacological therapy, hypertonia and behavioral issues persisted. The patient improved in engagement and emotional regulation during music therapy.Conclusion: We describe the developmental trajectory of an adolescent with overlapping Rett and Tourette syndromes carrying MECP2 and GABBR1 variants. Further studies are needed to clarify genotype-phenotype correlations and guide personalized therapeutic strategies.

Keywords: Rett Syndrome, Methyl CpG binding protein 2, Zappella Rett Syndrome clinical variant (Z-RTT), Preserved speech variant (PSV), GABAB, Intellectual Disability, tics and tourette syndrome

Received: 24 Apr 2025; Accepted: 03 Jun 2025.

Copyright: © 2025 Napoli, GUERRERA, Demaria, Piccolo, Cianfa, Passarini, Logrieco, Zanni, Valeri and Vicari. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
SILVIA GUERRERA, Child and Adolescent Neuropsychiatry Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
Ginevra Zanni, Developmental Neurology and Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.